In this June update, we've made four adjustments to the KBC Securities Dynamic Top Pick List: 1.Merus (Removed – 27 May) was removed following the release of strong interim Phase 2 data at the ASCO 2025 conference. Its lead asset, petosemtamab, in combination with Keytruda, showed a 63% overall response rate in first-line treatment of head and neck cancer—significantly outperforming Keytruda monotherapy. The resulting share price surge validated our investment thesis. 2. Adyen (Removed) has de...
Shurgard 1Q25 EPRA net came slightly ahead of our estimates as rental income performed better. The net EPRA amounted to 35.7m vs. 35.1m expected, and the property result beat with 111.6m vs. 108.4m exp.. Also Net Property result beat our expectation by 2%. The 1Q25 same store operating revenue growth of 6.2% beat our expectation by 0.8%. France showed 5.5% lfl growth after years of low single digits. The overall occupancy declined only 0.6%. This a strong performance and indicates the LnS integr...
The ongoing tariff war continues to create uncertainty for investors, with a trade embargo between the US and China. Although Europe has received a temporary reprieve, the prolonged situation could result in significant economic damage. We are maintaining a defensive stance in our Benelux Dynamic Top Pick List, as the Federal Reserve holds steady and the European Central Bank may continue lowering rates. Pessimism regarding the European industry has increased, though some US-based European compa...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.